Thermo Fisher Scientific (TMO) vs peers
TMO's EV/Sales is 6.4x, compared with 7.3x at the middle of 6 peers.
Life Sciences Tools & Services. Updated .
| Stock | EV/Sales | Own 5-year rank |
|---|---|---|
| TMOThermo Fisher Scientific | 6.4x | 93% |
| TECHBio-Techne | 9.3x | 35% |
| MTDMettler Toledo | 8.7x | 76% |
| DHRDanaher Corporation | 7.5x | 68% |
| AAgilent Technologies | 7.1x | 94% |
| CRLCharles River Laboratories | 4.8x | 91% |
| IQVIQVIA | 3.7x | 69% |
How to read this comparison
Up to eight covered companies in the same industry, largest market value first.
EV/Sales divides enterprise value (stock market value plus debt, less cash) by revenue from the previous twelve months. The middle peer reading excludes TMO and unavailable values.
Own 5-year rank compares each stock with its available weekly readings within the last five years. At least 26 usable weeks are required. A rank of 20% means its current multiple is above 20% of its past readings. It is not a rank against the other stocks in this table.
Dates show data updates; the latest available weekly observation can differ between stocks. Different growth rates, margins and financial risks can explain different multiples. Missing or non-positive denominators are left unranked.